Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Search results for:

439 match(es)

2013 Dublin (Ireland)

Presentations

Counterfeit Medicines in Egypt: Pharmacists' Perception of the Problem Dimensions and Combating Strategies

Counterfeit Medicines in Egypt: Pharmacists' Perception of the Problem Dimensions and Combating Strategies

August 31

F1- Pharmacy Technicians Symposium Session 1 Part A: The roles of pharmacy technicians in managing complex patients

F1- Pharmacy Technicians Symposium Session 1 Part B : The roles of pharmacy technicians in managing complex patients

F1- Pharmacy Technicians Symposium Session 2 : Complex patient case studies

September 1

F1- Pharmacy Technicians Symposium Session 3 Part A: Collaborative approaches to managing complex patients

F1- Pharmacy Technicians Symposium Session 3 Part B : Collaborative approaches to managing complex patients

F2- Pharmacy and pharamceutical sciences in Ireland

September 2

A1 - Why are patients complex?

B1 - Introduction session: Unmet needs of the complex patient

E3 - Translating expert knowledge into patient care

F12 - How can practitioners provide consumers with proper information on herbals in different regulatory systems

F17 - Presentations from FIP member organisations (Part 1)

F21 - Short oral presentations of the FIP Industrial Pharmacy Section

F5 - The complexity of health challenges in 2020: Are we ready?

F8 - Providing hospital pharmacy services to meet the needs of complex patients: Can the Basel Statements help?

F9 - Pharmacy practice in the face of globalism, ethics and regulation

Posters

September 3

B2 - Healthcare data: Safeguarding confidentiality

B3 - The need for better communication

C1 - Best practice in integrating drug therapy and patient care

C11 - Collaborative approaches to dealing with complex medical conditions

C13 - Diagnostics in individualized medicine and pharmacotherapy: What you need to know

C6 - Anticoagulation: Pharmacists at the bleeding edge of patient care

C7 - Remuneration and implementation of community pharmacy services to complex patients

C8 - Trends in Community Pharmacy: Debating the future of the profession

D1 - Implementing the vision

E1 - Science: The best basis for the best practice?

F11 - The value of real world evidence - will availability of data lead to a paradigm change?

F13 - FIP Host Madsen Medal Lecture

F18 - Presentations from FIP member organisations (Part 2)

F23 - Short oral presentations of the FIP Pharmacy Information Section

F3 - Conclusions of the chief pharmacists' meeting

September 4

C1 - Best practice in integrating drug therapy and patient care

C10 - Complex patients and obstacles to quality use of medicines - a patient‘s perspective

C12 - Computer prompts versus clinical freedom (debate)

C2 - Managing patients with cancer: The role of the pharmacist

C3 - Managing patients with renal impairment: The role of the pharmacist

D2 - High-quality support: The ultimate target of pharmacologistics

D3 - The diversity of patients and its influence on pharmacoepidemiological research

D4 - The diversity of social networks - Their influence on patient care

D6 - The emergence of biologicals as therapeutic agents

E2 - Interprofessional education

F14 - Process validation

F15 - Improving communication between healthcare providers in disaster situations

F16 - Pharmacists in humanitarian work

F19 - Presentations from FIP member organisations (Part 3)

F22 - Short oral presentations of the FIP Community Pharmacy Section

F26 - Report on the Pharmacopoeia Meeting in India

F6 - Creating the future leaders in pharmacy

Pharmabridge

September 5

C4 - Managing patients with asthma: The role of the pharmacist

C5 - Managing mentally ill patients: The role of the pharmacist

C9 - The role of compounding in closing therapeutic gaps (Parts 1 and 2)

D5 - Pharmacy Practice Research: Assessing the evidence and research needs of integrated care for complex patients

D7 - Fast forward to the future: Translating science into better patient care

D8 - How patient stratification and pharmacogenetics affect ADRs in complex patients

D9 - Individual therapy, individual care - optimization in the face of complexity

E4 - Addressing global complexities through educational innovation

F10 - Commitment to ethical responsibility and professional autonomy in pharmacy

F20 - Presentations from FIP member organisations (part 4)

F24 - Short oral presentations of the FIP Social and Administrative Pharmacy Section

F25 - History of Pharmacy

F27 - Short oral presentations of the FIP Academic Pharmacy Section

F7 - Leadership session for young leaders

Poster and Presentations

Academic Pharmacy

Academic Pharmacy: Addressing global complexities through educational innovation

Community Pharmacy

Formulation Design and Pharmaceutical Technology

Industrial Pharmacy

Pharmacy Information

Pharmacy Practice Research

Social and Administrative Pharmacy

Poster

Academic Pharmacy

Academic Pharmacy: Addressing global complexities through educational innovation

Analytical Sciences and Pharmaceutical Quality

Biotechnology

Clinical Biology

Community Pharmacy

Community Pharmacy: Emerging strategies for handling complex patients

Community Pharmacy: Unmet needs of complex patients

Community Pharmacy: What are we doing to meet the needs of complex patients?

Drug Design and Discovery

Formulation Design and Pharmaceutical Technology

History of Pharmacy

Hospital Pharmacy

Industrial Pharmacy

Laboratory and Medicines Control Services

Military & Emergency Pharmacy

Natural Products

Pharmacokinetics, Pharmacodynamics, Absorption, Distribution, Metabolism and Excretion

Pharmacy Information

Pharmacy Practice Research

Pharmacy Technicians

Regulatory Sciences

Social and Administrative Pharmacy

Translational Research and Individualized Medicines

Biography

Press

Last update 13 May 2019

FIP Congresses